Comments on: Interview With Garrett Herman Yields More Detail on the LOM-BioQuest Joint Venture http://crossborderbiotech.ca/2009/08/18/interview-with-garrett-herman-yeilds-more-detail-on-the-lom-bioquest-joint-venture/ Biotechnology, Health and Business in Canada, the United States and Worldwide Sat, 10 Dec 2011 04:09:15 +0000 hourly 1 http://wordpress.com/ By: Monday Biotech Deal Review: October 25, 2009 « The Cross-Border Biotech Blog http://crossborderbiotech.ca/2009/08/18/interview-with-garrett-herman-yeilds-more-detail-on-the-lom-bioquest-joint-venture/comment-page-1/#comment-1053 Mon, 26 Oct 2009 13:53:50 +0000 http://crossborderbiotech.ca/?p=2937#comment-1053 [...] week.  Loewen, Ondaatje, McCutcheon Limited and Versant Partners Inc. are the co-lead agents (no LOM-BioQuest angle here?).  The offering is priced at $0.48 per share, for gross proceeds to iCo of [...]

]]>